U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Malignant Pharyngeal Neoplasm

MedGen UID:
1654336
•Concept ID:
C4725808
•
Neoplastic Process

Definition

Malignant pharyngeal neoplasm that is resistant to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory Malignant Pharyngeal Neoplasm

Professional guidelines

PubMed

Feasibility and potential value of lipofilling in post-treatment oropharyngeal dysfunction.
Kraaijenga SA, Lapid O, van der Molen L, Hilgers FJ, Smeele LE, van den Brekel MW
Laryngoscope 2016 Dec;126(12):2672-2678. Epub 2016 Apr 14 doi: 10.1002/lary.26003. PMID: 27076387
Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review.
Fox NF, Xiao C, Sood AJ, Lovelace TL, Nguyen SA, Sharma A, Day TA
Oral Surg Oral Med Oral Pathol Oral Radiol 2015 Jul;120(1):22-8. Epub 2015 Mar 25 doi: 10.1016/j.oooo.2015.03.007. PMID: 26093680
Treatment of head and neck cancers: issues for clinical pharmacists.
Scarpace SL, Brodzik FA, Mehdi S, Belgam R
Pharmacotherapy 2009 May;29(5):578-92. doi: 10.1592/phco.29.5.578. PMID: 19397465

Recent clinical studies

Etiology

The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
Tang LQ, Li XY, Li ZM, Liu ZG, Lin MZ, Zhou H, Yu QW, Zhou J, Zhao C, Chen ZB, Wang XC, Peng JY, Chen QY, Fang WF, Yang YP, Zhang B, Xia LP, Hu PL, Hu WH, Li YJ, Mai HQ, Cai XY
BMC Med 2023 Mar 16;21(1):94. doi: 10.1186/s12916-023-02790-1. PMID: 36927541Free PMC Article
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, Liao W, Jiang Y, Lin XY, Zhang QY, Yuan XL, Huang HX, Chen Y, Dai GH, Shi JH, Shen L, Yang SJ, Shu YQ, Liu YP, Wang W, Wu H, Feng H, Yao S, Xu RH
J Clin Oncol 2021 Mar 1;39(7):704-712. Epub 2021 Jan 25 doi: 10.1200/JCO.20.02712. PMID: 33492986Free PMC Article
Future of Radiotherapy in Nasopharyngeal Carcinoma.
Sun XS, Li XY, Chen QY, Tang LQ, Mai HQ
Br J Radiol 2019 Oct;92(1102):20190209. Epub 2019 Jul 9 doi: 10.1259/bjr.20190209. PMID: 31265322Free PMC Article
Cellular-based immunotherapy in Epstein-Barr virus induced nasopharyngeal cancer.
Lee AZE, Tan LSY, Lim CM
Oral Oncol 2018 Sep;84:61-70. Epub 2018 Jul 20 doi: 10.1016/j.oraloncology.2018.07.011. PMID: 30115477
Treatment of head and neck cancers: issues for clinical pharmacists.
Scarpace SL, Brodzik FA, Mehdi S, Belgam R
Pharmacotherapy 2009 May;29(5):578-92. doi: 10.1592/phco.29.5.578. PMID: 19397465

Diagnosis

Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
Dandasena T, Ingle V, Singhai A, Saigal S
BMJ Case Rep 2023 Dec 11;16(12) doi: 10.1136/bcr-2023-254702. PMID: 38081733Free PMC Article
Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma.
Wu YX, Xing S, Wang Y, Tian BY, Wu M, Wang XP, Huang Q, He X, Chen SL, Li XH, Zeng MS, Liu WL
J Immunother Cancer 2023 Aug;11(8) doi: 10.1136/jitc-2022-006552. PMID: 37536937Free PMC Article
EBV-positive mucocutaneous ulcer presenting as a nasopharyngeal tumor in an immune suppressed patient.
Law RH, Rizzi MD
Am J Otolaryngol 2023 Jan-Feb;44(1):103685. Epub 2022 Oct 22 doi: 10.1016/j.amjoto.2022.103685. PMID: 36323155
Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.
Jiang J, Tang Q, Gong J, Jiang W, Chen Y, Zhou Q, Aldeen A, Wang S, Li C, Lv W, Du T, Wang X, Long X, Feng X
Int J Biol Sci 2022;18(5):1878-1895. Epub 2022 Feb 21 doi: 10.7150/ijbs.69934. PMID: 35342334Free PMC Article
Controlled sedation for refractory symptoms in dying patients.
Mercadante S, Intravaia G, Villari P, Ferrera P, David F, Casuccio A
J Pain Symptom Manage 2009 May;37(5):771-9. Epub 2008 Nov 28 doi: 10.1016/j.jpainsymman.2008.04.020. PMID: 19041216

Therapy

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Yuan L, Jia GD, Lv XF, Xie SY, Guo SS, Lin DF, Liu LT, Luo DH, Li YF, Deng SW, Guo L, Zeng MS, Cai XY, Liu SL, Sun XS, Li XY, Li SC, Chen QY, Tang LQ, Mai HQ
Nat Commun 2023 Aug 14;14(1):4893. doi: 10.1038/s41467-023-40402-x. PMID: 37580352Free PMC Article
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
Tang LQ, Li XY, Li ZM, Liu ZG, Lin MZ, Zhou H, Yu QW, Zhou J, Zhao C, Chen ZB, Wang XC, Peng JY, Chen QY, Fang WF, Yang YP, Zhang B, Xia LP, Hu PL, Hu WH, Li YJ, Mai HQ, Cai XY
BMC Med 2023 Mar 16;21(1):94. doi: 10.1186/s12916-023-02790-1. PMID: 36927541Free PMC Article
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study.
Ding X, Zhang WJ, You R, Zou X, Wang ZQ, Ouyang YF, Peng L, Liu YP, Duan CY, Yang Q, Lin C, Xie YL, Chen SY, Liu YL, Gu CM, Xie RQ, Huang PY, Hong MH, Hua YJ, Chen MY
J Clin Oncol 2023 May 10;41(14):2571-2582. Epub 2023 Feb 3 doi: 10.1200/JCO.22.01450. PMID: 36735896Free PMC Article
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, Liao W, Jiang Y, Lin XY, Zhang QY, Yuan XL, Huang HX, Chen Y, Dai GH, Shi JH, Shen L, Yang SJ, Shu YQ, Liu YP, Wang W, Wu H, Feng H, Yao S, Xu RH
J Clin Oncol 2021 Mar 1;39(7):704-712. Epub 2021 Jan 25 doi: 10.1200/JCO.20.02712. PMID: 33492986Free PMC Article
Camrelizumab: First Global Approval.
Markham A, Keam SJ
Drugs 2019 Aug;79(12):1355-1361. doi: 10.1007/s40265-019-01167-0. PMID: 31313098

Prognosis

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Yuan L, Jia GD, Lv XF, Xie SY, Guo SS, Lin DF, Liu LT, Luo DH, Li YF, Deng SW, Guo L, Zeng MS, Cai XY, Liu SL, Sun XS, Li XY, Li SC, Chen QY, Tang LQ, Mai HQ
Nat Commun 2023 Aug 14;14(1):4893. doi: 10.1038/s41467-023-40402-x. PMID: 37580352Free PMC Article
Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma.
Wu YX, Xing S, Wang Y, Tian BY, Wu M, Wang XP, Huang Q, He X, Chen SL, Li XH, Zeng MS, Liu WL
J Immunother Cancer 2023 Aug;11(8) doi: 10.1136/jitc-2022-006552. PMID: 37536937Free PMC Article
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.
Secondino S, Pedrazzoli P, Basso S, Bossi P, Bianco A, Imarisio I, Pagani A, De Cicco M, Muscianisi S, Casanova M, Morosi C, Bergamini C, Benazzo M, Cossu Rocca M, Perotti C, Baldanti F, Zecca M, Licitra LF, Comoli P
Front Immunol 2023;14:1208475. Epub 2023 Jul 11 doi: 10.3389/fimmu.2023.1208475. PMID: 37497213Free PMC Article
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, Liao W, Jiang Y, Lin XY, Zhang QY, Yuan XL, Huang HX, Chen Y, Dai GH, Shi JH, Shen L, Yang SJ, Shu YQ, Liu YP, Wang W, Wu H, Feng H, Yao S, Xu RH
J Clin Oncol 2021 Mar 1;39(7):704-712. Epub 2021 Jan 25 doi: 10.1200/JCO.20.02712. PMID: 33492986Free PMC Article
Nasopharyngeal carcinoma: the next challenges.
Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K
Eur J Cancer 2010 Jul;46(11):1967-78. Epub 2010 May 5 doi: 10.1016/j.ejca.2010.04.004. PMID: 20451372

Clinical prediction guides

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Yuan L, Jia GD, Lv XF, Xie SY, Guo SS, Lin DF, Liu LT, Luo DH, Li YF, Deng SW, Guo L, Zeng MS, Cai XY, Liu SL, Sun XS, Li XY, Li SC, Chen QY, Tang LQ, Mai HQ
Nat Commun 2023 Aug 14;14(1):4893. doi: 10.1038/s41467-023-40402-x. PMID: 37580352Free PMC Article
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
Tang LQ, Li XY, Li ZM, Liu ZG, Lin MZ, Zhou H, Yu QW, Zhou J, Zhao C, Chen ZB, Wang XC, Peng JY, Chen QY, Fang WF, Yang YP, Zhang B, Xia LP, Hu PL, Hu WH, Li YJ, Mai HQ, Cai XY
BMC Med 2023 Mar 16;21(1):94. doi: 10.1186/s12916-023-02790-1. PMID: 36927541Free PMC Article
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02).
Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, Liao W, Jiang Y, Lin XY, Zhang QY, Yuan XL, Huang HX, Chen Y, Dai GH, Shi JH, Shen L, Yang SJ, Shu YQ, Liu YP, Wang W, Wu H, Feng H, Yao S, Xu RH
J Clin Oncol 2021 Mar 1;39(7):704-712. Epub 2021 Jan 25 doi: 10.1200/JCO.20.02712. PMID: 33492986Free PMC Article
Future of Radiotherapy in Nasopharyngeal Carcinoma.
Sun XS, Li XY, Chen QY, Tang LQ, Mai HQ
Br J Radiol 2019 Oct;92(1102):20190209. Epub 2019 Jul 9 doi: 10.1259/bjr.20190209. PMID: 31265322Free PMC Article
Cellular-based immunotherapy in Epstein-Barr virus induced nasopharyngeal cancer.
Lee AZE, Tan LSY, Lim CM
Oral Oncol 2018 Sep;84:61-70. Epub 2018 Jul 20 doi: 10.1016/j.oraloncology.2018.07.011. PMID: 30115477

Recent systematic reviews

Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review.
Fox NF, Xiao C, Sood AJ, Lovelace TL, Nguyen SA, Sharma A, Day TA
Oral Surg Oral Med Oral Pathol Oral Radiol 2015 Jul;120(1):22-8. Epub 2015 Mar 25 doi: 10.1016/j.oooo.2015.03.007. PMID: 26093680

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...